Curable (XKRX:086460) EV-to-EBITDA : (As of Jun. 25, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curable EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Curable's enterprise value is ₩21,913.5 Mil. Curable does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's EV-to-EBITDA at this moment.

The historical rank and industry rank for Curable's EV-to-EBITDA or its related term are showing as below:

XKRX:086460' s EV-to-EBITDA Range Over the Past 10 Years
Min: -40.11 Med: -4.15 Max: 0.67
Current: -3.76

During the past 3 years, the highest EV-to-EBITDA of Curable was 0.67. The lowest was -40.11. And the median was -4.15.

XKRX:086460's EV-to-EBITDA is ranked worse than
100% of 110 companies
in the Medical Diagnostics & Research industry
Industry Median: 14.605 vs XKRX:086460: -3.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), Curable's stock price is ₩4145.00. Curable does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Curable EV-to-EBITDA Historical Data

The historical data trend for Curable's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable EV-to-EBITDA Chart

Curable Annual Data

Trend

Dec21

Dec22

Dec23

EV-to-EBITDA

0.53

-50.94

-4.97

Curable Semi-Annual Data
	Dec21	Dec22	Dec23
EV-to-EBITDA	-	-50.94	-4.97

Competitive Comparison of Curable's EV-to-EBITDA

For the Diagnostics & Research subindustry, Curable's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curable's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Curable's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curable's EV-to-EBITDA falls into.

Curable EV-to-EBITDA Calculation

Curable's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	21913.451	/
	=

Curable (XKRX:086460) EV-to-EBITDA Explanation

Curable's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	4145.00	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Curable EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curable's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Curable (XKRX:086460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.snp-genetics.com

Curable Inc provides genome analysis service.

Curable (XKRX:086460) Headlines

No Headlines